Next PageExport DataImport DataReset Form Form Approved: OMB No. 09100014 Expiration Date: February 28, 2019 See PRA Statement on page 3.DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug AdministrationINVESTIGATIONAL.
Open form follow the instructions
Easily sign the form with your finger
Send filled & signed form or save
How to fill out the FDA 1571 online
Filling out the FDA 1571 form is a crucial step for sponsors seeking an investigational new drug application. This guide provides a comprehensive step-by-step approach to help users navigate the form online with clarity and confidence.
Follow the steps to successfully complete the FDA 1571 form online.
- Click ‘Get Form’ button to obtain the FDA 1571 form and open it in your preferred online editor.
- In the first section, enter the name of the sponsor. This should include the full legal name of the entity submitting the application.
- Next, provide the date of submission in the format mm/dd/yyyy, ensuring accuracy to avoid processing delays.
- Input the sponsor's address, including street address, city, state/province/region, country, and ZIP or postal code.
- Include the sponsor's telephone number, making sure to include the country code if applicable.
- If an IND number has been previously assigned, enter it in the designated field. If this is the first submission, leave this field blank.
- Select whether the application is for commercial or research purposes by checking the appropriate box.
- List the name of the drug, ensuring that all available names (trade, generic, chemical, or code) are included.
- Describe the proposed indication for use. Determine if it is for a rare disease and indicate if there is an FDA orphan designation for it.
- Specify the phase of clinical investigation to be conducted (Phase 1, 2, 3, or other) and provide necessary details.
- List all relevant investigational new drug applications, new drug applications, drug master files, and biologics license applications referenced in this application.
- Provide the initial serial number as ‘0000’ and make sure to sequentially number any subsequent submissions.
- Indicate which items are included in this submission by selecting all that apply from the options provided.
- Identify whether the product is a combination product and provide justification if applicable.
- If a contract research organization will conduct any part of the study, provide the necessary details as specified.
- Input the name and title of the person responsible for monitoring the study's progress along with their contact information.
- Acknowledge the agreement statement regarding clinical investigations. Ensure the sponsor name, title, and contact details are correctly filled in.
- Finalize the document by entering the sponsor's and countersigner's names, addresses, email addresses, and signatures.
- Once all sections are completed, users can save changes, download, print, or share the form as needed.
Complete your FDA 1571 application online today to ensure compliance and streamline your submission process.
Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Related content
Sep 7, 2023 — FDA has revised form 356h: Application to Market a New or Abbreviated New...
Form FDA 1571. Completed by the IND Sponsor and must be included on all submissions made...
Form FDA 1571 or Form FDA 356h ... Form FDA 1571 or Form FDA 356h. 94. 95. All electronic...
Get answers to your most pressing questions about US Legal Forms API.
How to get FDA approval for your product?
To achieve FDA approval for your product, you must navigate the regulatory process, starting with the completion of the FDA 1571 form. This form is integral to your IND application and outlines essential information about your product. You should gather all required documentation and submit it through the FDA's electronic system to ensure compliance and expedite the review process.
How do I submit FDA approval?
To obtain FDA approval, you need to submit an application that includes the FDA 1571 form, clinical trial data, and any analysis highlighting your product's effectiveness. It’s important to follow the submission guidelines provided by the FDA to ensure your documents meet all necessary requirements. Consider using platforms like uslegalforms to simplify the application process and ensure accuracy in your submissions.
How many days does the FDA have to respond to a request from an investigator sponsor for an IND?
The FDA has 30 days to respond to requests for an IND application submitted under Form 1571. During this time, the FDA reviews all submitted data to assess the safety and quality of the proposed studies. Therefore, it is crucial to prepare your FDA 1571 thoroughly to avoid delays in the approval process.
When should the FDA form 1571 be used?
You should use the FDA 1571 form whenever you plan to conduct clinical investigations involving a new drug for human subjects. This form is mandatory for submitting an IND application, which is necessary before any trial can begin. By completing this form, you ensure that your study complies with FDA standards and protects the welfare of participants.
What is Form 1571 in clinical research?
Form 1571, also known as the Investigational New Drug Application, serves as a formal request to the FDA to initiate clinical trials for a new drug. This form outlines critical details about your drug, including its chemical structure, proposed use, and information about the clinical study design. Utilizing Form 1571 is essential for researchers to ensure alignment with FDA regulations while developing innovative treatments.
How to submit for FDA approval?
To submit for FDA approval, you need to prepare a comprehensive application that includes data on the safety and efficacy of your product. A crucial part of this process is completing the FDA 1571 form, which provides essential information about your Investigational New Drug (IND) application. Once your form is ready, submit it through the FDA’s electronic submission system to ensure it meets all regulatory standards.
How do I file a report with the FDA?
Filing a report with the FDA can be done through their online reporting system or by submitting a paper form. It is essential to include all relevant details to ensure your report is processed efficiently. Following the proper channels is vital, as it helps the FDA take necessary actions promptly. Leveraging the FDA 1571 can serve as a guide and improve your reporting accuracy.
What is a reportable event for FDA?
A reportable event for the FDA includes any incident that could impact the safety or effectiveness of a product. This might include serious injuries, product defects, or any situation that compromises public health. Timely reporting is crucial for ensuring consumer safety. Utilizing the FDA 1571 can help in documenting and reporting these events effectively.
How do I submit documents to the FDA?
Submitting documents to the FDA typically involves using the FDA's electronic submission gateway or mailing them directly to the agency. Ensure all documents are complete and clear to prevent any processing delays. Using tools like the FDA 1571 can help organize necessary information for submission. Always follow the latest guidelines from the FDA regarding document submissions.
How do I report suspicious activity to the FDA?
To report suspicious activity to the FDA, you can use their dedicated hotline or online reporting form. Providing specific details about the incident can greatly assist the agency in investigating the issue. This process ensures that any potential threats to public health are addressed swiftly. Remember, using FDA 1571 could help in structuring your report, emphasizing the necessary details.
Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
If you believe that this page should be taken down, please follow our DMCA take down process here.
This form is available in several versions. Select the version you need from the drop-down list below.